Tolgabide
An overview of the medication Tolgabide
Overview[edit | edit source]
Tolgabide is a pharmaceutical compound used primarily in the treatment of certain neurological disorders. It is classified as an anticonvulsant and is known for its efficacy in managing epilepsy and related conditions. Tolgabide works by modulating the activity of neurotransmitters in the brain, thereby stabilizing neuronal activity and preventing seizures.
Mechanism of Action[edit | edit source]
Tolgabide functions by enhancing the inhibitory effects of gamma-aminobutyric acid (GABA), a key neurotransmitter in the central nervous system. By increasing GABAergic activity, Tolgabide helps to reduce the excitability of neurons, which is crucial in controlling seizure activity. This mechanism is similar to other anticonvulsants, but Tolgabide is noted for its specific binding affinity and modulation of GABA receptors.
Clinical Uses[edit | edit source]
Tolgabide is primarily indicated for the management of:
In addition to its use in epilepsy, Tolgabide has been explored for potential benefits in treating other neurological conditions, such as bipolar disorder and certain types of neuropathic pain.
Side Effects[edit | edit source]
Common side effects of Tolgabide include:
Less common but more serious side effects can include:
Patients are advised to monitor for any adverse effects and report them to their healthcare provider.
Dosage and Administration[edit | edit source]
Tolgabide is typically administered orally, with dosage tailored to the individual patient's needs and response to the medication. It is important for patients to adhere to the prescribed dosage regimen to maintain therapeutic levels and minimize the risk of seizures.
Pharmacokinetics[edit | edit source]
Tolgabide is absorbed in the gastrointestinal tract and undergoes hepatic metabolism. It has a half-life that allows for dosing once or twice daily, depending on the formulation and clinical requirements. The drug is excreted primarily through the kidneys.
Contraindications[edit | edit source]
Tolgabide is contraindicated in patients with:
- Known hypersensitivity to the drug
- Severe hepatic impairment
Caution is advised when prescribing Tolgabide to patients with renal impairment or those taking other medications that affect liver enzymes.
Related pages[edit | edit source]
Gallery[edit | edit source]
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
WikiMD's Wellness Encyclopedia |
Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD